153 related articles for article (PubMed ID: 11232854)
1. Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method.
Barker SA; Littlefield-Chabaud MA; David C
J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):37-47. PubMed ID: 11232854
[TBL] [Abstract][Full Text] [Related]
2. Ontogeny of N,N-dimethyltryptamine and related indolealkylamine levels in neonatal rats.
Beaton JM; Morris PE
Mech Ageing Dev; 1984 Jun; 25(3):343-7. PubMed ID: 6588281
[TBL] [Abstract][Full Text] [Related]
3. LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate.
Barker SA; Borjigin J; Lomnicka I; Strassman R
Biomed Chromatogr; 2013 Dec; 27(12):1690-700. PubMed ID: 23881860
[TBL] [Abstract][Full Text] [Related]
4. Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
Forsström T; Tuominen J; Karkkäinen J
Scand J Clin Lab Invest; 2001; 61(7):547-56. PubMed ID: 11763413
[TBL] [Abstract][Full Text] [Related]
5. Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.
Lanaro R; Mello SM; da Cunha KF; Silveira G; Corrêa-Neto NF; Hyslop S; Cabrices OG; Costa JL; Linardi A
Drug Test Anal; 2021 Mar; 13(3):664-678. PubMed ID: 33119972
[TBL] [Abstract][Full Text] [Related]
6. Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; Method development and application.
Körmöczi T; Szabó Í; Farkas E; Penke B; Janáky T; Ilisz I; Berkecz R
J Pharm Biomed Anal; 2020 Nov; 191():113615. PubMed ID: 32942106
[TBL] [Abstract][Full Text] [Related]
7. Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma.
Eckernäs E; Bendrioua A; Cancellerini C; Timmermann C; Carhart-Harris R; Hoffmann KJ; Ashton M
J Pharm Biomed Anal; 2022 Apr; 212():114642. PubMed ID: 35149418
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
Halberstadt AL
Pharmacol Biochem Behav; 2016 Apr; 143():1-10. PubMed ID: 26780349
[TBL] [Abstract][Full Text] [Related]
9. "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli".
Friedberg LM; Sen AK; Nguyen Q; Tonucci GP; Hellwarth EB; Gibbons WJ; Jones JA
Metab Eng; 2023 Jul; 78():61-71. PubMed ID: 37230161
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect.
Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
Biochem Pharmacol; 1982 Aug; 31(15):2513-6. PubMed ID: 6812592
[TBL] [Abstract][Full Text] [Related]
11. Identification of N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine and bufotenin by cellulose TLC.
Baumann P; Narasimhachari
J Chromatogr; 1973 Nov; 86(1):269-73. PubMed ID: 4358118
[No Abstract] [Full Text] [Related]
12. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.
Riba J; McIlhenny EH; Bouso JC; Barker SA
Drug Test Anal; 2015 May; 7(5):401-6. PubMed ID: 25069786
[TBL] [Abstract][Full Text] [Related]
13. Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry.
Gaujac A; Dempster N; Navickiene S; Brandt SD; de Andrade JB
Talanta; 2013 Mar; 106():394-8. PubMed ID: 23598143
[TBL] [Abstract][Full Text] [Related]
14. Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies.
Sitaram BR; McLeod WR
Biol Psychiatry; 1990 Nov; 28(10):841-8. PubMed ID: 2268688
[TBL] [Abstract][Full Text] [Related]
15. Gas chromatographic-mass spectroscopic characterisation of the psychotomimetic indolealkylamines and their in vivo metabolites.
Sitaram BR; Lockett L; McLeish M; Hayasaka Y; Blackman GL; McLeod WR
J Chromatogr; 1987 Nov; 422():13-23. PubMed ID: 3481368
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of substituted N,N-dimethyl-tryptamines in the presence of natural type XII alkaloids.
Ivanova B; Spiteller M
Nat Prod Commun; 2012 Oct; 7(10):1273-6. PubMed ID: 23156988
[TBL] [Abstract][Full Text] [Related]
17. Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues.
Kärkkäinen J; Forsström T; Tornaeus J; Wähälä K; Kiuru P; Honkanen A; Stenman UH; Turpeinen U; Hesso A
Scand J Clin Lab Invest; 2005; 65(3):189-99. PubMed ID: 16095048
[TBL] [Abstract][Full Text] [Related]
18. Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma.
Walker RW; Ahn HS; Albers-Schönberg G; Mandel LR; Vandenheuvel WJ
Biochem Med; 1973 Aug; 8(1):105-13. PubMed ID: 4582927
[No Abstract] [Full Text] [Related]
19. Studies on neurosteroids. VII. Determination of pregnenolone and its 3-stearate in rat brains using high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
Shimada K; Mukai Y
J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):153-60. PubMed ID: 9766855
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the synthesis of N,N-dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry.
Brandt SD; Moore SA; Freeman S; Kanu AB
Drug Test Anal; 2010 Jul; 2(7):330-8. PubMed ID: 20648523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
